Skip to main content
. 2015 Mar 5;45(5):1434–1445. doi: 10.1183/09031936.00174914

FIGURE 2.

FIGURE 2

Crystal structure of nintedanib bound to the active site of the fibroblast growth factor receptor-1 kinase domain. The inhibitor and residues that line the active site are shown in stick representation. Hydrogen bonds are depicted as yellow dots. Key residues are labelled.

HHS Vulnerability Disclosure